Treatment of complications by invasive procedures for prenatal diagnosis

doi:10.3877/cma.j.issn.2095-3259.2018.01.007

Abstract

Abstract:

The invasive prenatal diagnosis is obtained cells from the fetus through chorionic villus sampling, amniocentesis, cordocentesis and fetal biopsy to determine chromosomal or genetic disorders in the fetus during first trimester and second trimester, which is in order to diagnose fetal congenital disease before birth. The related complications include fetal loss, bleeding, amniotic fluid leakage, premature rupture of membranes, infection, fetal bradycardia, fetal injury and maternal complications related to the operation. Early identification and treatment of complications help to reduce the maternal-fetal risk.

Key words: Prenatal diagnosis, Punctures, Chorion, Amniotic fluid, Fetal blood, Complication

Linhuan Huang, Zilian Wang. Treatment of complications by invasive procedures for prenatal diagnosis[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2018, 07(01): 30-34.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2018.01.007

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2018/V07/I01/30

References 47

[1]	American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy [J]. Obstet Gynecol, 2007, 110(6): 1459-1467.
[2]	Royal College of Obstetricians and Gynaecologists (RCOG). Amniocentesis and Chorionic Villus Sampling[R]. Green Top Guideline No.8. London: RCOG Press, 2010.
[3]	Papp C, Beke A, Mezei G, et al. Chorionic villus sampling: a 15-year experience [J]. Fetal Diagn Ther, 2002, 17(4): 218-227.
[4]	Tabor A, Vestergaard CH, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study [J]. Ultrasound Obstet Gynecol, 2009, 34(1): 19-24.
[5]	Wulff CB, Gerds TA, Rode L, et al. The risk of fetal loss associated with invasive testing following combined first trimester risk screening for Down syndrome-a national cohort of 147 987 singleton pregnancies [J]. Ultrasound Obstet Gynecol, 2016, 47(1): 38-44.
[6]	Odibo AO, Dicke JM, Gray DL, et al. Evaluating the rate and risk factors for fetal loss after chorionic villus sampling [J]. Obstet Gynecol, 2008, 112(4): 813-819.
[7]	Akolekar R, Beta J, Picciarelli G, et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis [J]. Ultrasound Obstet Gynecol, 2015, 45(1): 16-26.
[8]	Milunsky A. Genetic disorders and the fetus: diagnosis, prevention, and Treatment [M]. 5th ed. Baltimore (MD): Johns Hopkins University Press, 2004: 1-65.
[9]	Brambati B, Tului L, Cislaghi C, et al. First 10, 000 chorionic villus samplings performed on singleton pregnancies by a single operator [J]. Prenat Diagn, 1998, 18(3): 255-266.
[10]	Akolekar R, Bower S, Flack N, et al. Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling [J]. Prenat Diagn, 2011, 31(1): 38-45.
[11]	Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women [J]. Lancet, 1986, 1(8493): 1287-1293.
[12]	Uludag S, Aydin Y, Ibrahimova F, et al. Comparison of complications in second trimester amniocentesis performed with 20G, 21G and 22G needles [J]. J Perinat Med, 2010, 38(6): 597-600.
[13]	Seeds JW. Diagnostic mid trimester amniocentesis: how safe? [J]. Am J Obstet Gynecol, 2004, 191(2): 607-615.
[14]	Kahler C, Gembruch U, Heling KS, et al. DEGUM guidelines for amniocentesis and chorionic villus sampling [J]. Ultraschall Med, 2013, 34(5): 435-440.
[15]	Towner D, Currier RJ, Lorey FW, et al. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening [J]. Am J Obstet Gynecol, 2007, 196(6): 608.e1-608.e5.
[16]	Harper LM, Cahill AG, Smith K, et al. Effect of maternal obesity on the risk of fetal loss after amniocentesis and chorionic villus sampling [J]. Obstet Gynecol, 2012, 119(4): 745-751.
[17]	Tongsong T, Wanapirak C, Kunavikatikul C, et al. Fetal loss rate associated with cordocentesis at midgestation [J]. Am J Obstet Gynecol, 2001, 184(4): 719-723.
[18]	Maxwell DJ, Johnson P, Hurley P, et al. Fetal blood sampling and pregnancy loss in relation to indication [J]. Br J Obstet Gynaecol, 1991, 98(9): 892-897.
[19]	Antsaklis A, Daskalakis G, Papantoniou N, et al. Fetal blood sampling－－indication-related losses [J]. Prenat Diagn, 1998, 18(9): 934-940.
[20]	Ghidini A, Sepulveda W, Lockwood CJ, et al. Complications of fetal blood sampling [J]. Am J Obstet Gynecol, 1993, 168(5): 1339-1344.
[21]	Liao C, Wei J, Li Q, et al. Efficacy and safety of cordocentesis for prenatal diagnosis [J]. Int Gynecol Obstet, 2006, 93(1): 13-17.
[22]	Jahoda MG, Pijpers L, Reuss A, et al. Evaluation of transcervical chorionic villus sampling with a completed follow-up of 1550 consecutive pregnancies [J]. Prenat Diagn, 1989, 9(9): 621-628.
[23]	Athanasiadis AP, Pantazis K, Goulis DG, et al. Comparison between 20G and 22G needle for second trimester amniocentesis in terms of technical aspects and short-term complications [J]. Prenat Diagn, 2009, 29(8): 761-765.
[24]	Hogge WA, Thiagarajah S, Brenbridge AN, et al. Fetal evaluation by percutaneous blood sampling [J]. Am J Obstet Gynecol, 1988, 158(1): 132-136.
[25]	Rujiwetpongstorn J, Tongsong T, Wanapirak C. Feto-maternal hemorrhage after cordocentesis at Maharaj Nakorn Chiang Mai Hospital [J]. J Med Assoc Thai, 2005, 88(2): 145-149.
[26]	Weiner CP, Wenstrom KD, Sipes SL, et al. Risk factors for cordocentesis and fetal intravascular transfusion [J]. Am J Obstet Gynecol, 1991, 165(4 Pt 1): 1020-1025.
[27]	Jauniaux E, Donner C, Simon P, et al. Pathologic aspects of the umbilical cord after percutaneous umbilical blood sampling [J]. Obstet Gynecol, 1989, 73(2): 215-218.
[28]	Brambati B, Lanzani A, Tului L. Transabdominal and transcervical chorionic villus sampling: efficiency and risk evaluation of 2, 411 cases [J]. Am J Med Genet, 1990, 35(2): 160-164.
[29]	Philip J, Silver RK, Wilson RD, et al. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial [J]. Obstet Gynecol, 2004, 103(6): 1164-1173.
[30]	Borgida AF, Mills AA, Feldman DM, et al. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis [J]. Am J Obstet Gynecol, 2000, 183(4): 937-939.
[31]	Devlieger R, Millar LK, Bryant-Greenwood G, et al. Fetal membrane healing after spontaneous and iatrogenic membrane rupture: a review of current evidence [J]. Am J Obstet Gynecol, 2006, 195(6): 1512-1520.
[32]	Ghi T, Sotiriadis A, Calda P, et al. ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis [J]. Ultrasound Obstet Gynecol, 2016, 48(2): 256-268.
[33]	Giorlandino C, Cignini P, Cini M, et al. Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial [J]. Prenat Diagn, 2009, 29(6): 606-612.
[34]	Hobbins JC, Pilu G, Abuhumad A, et al. Antibiotic prophylaxis before amniocentesis [J]. Prenat Diagn, 2011, 31(12): 1213-1214.
[35]	Gramellini D, Fieni S, Casilla G, et al. Mid-trimesteramniocentesis and antibiotic prophylaxis [J]. Prenat Diagn, 2007, 27(10): 956-959.
[36]	Mujezinovic F, Alfirevic Z. Technique modifications for reducing the risks from amniocentesis or chorionic villus sampling [J]. Cochrane Database Syst Rev, 2012, 8: CD008678.
[37]	Boulot P, Deschamps F, Lefort G, et al. Pure fetal blood samples obtained by cordocentesis: Technical aspects of 322 cases [J]. Prenat Diagn, 1990, 10(2): 93-100.
[38]	Wladimiroff JW, Sachs ES, Reuss A, et al. Prenatal diagnosis of chromosome abnormalities in the presence of fetal structural defects [J]. Am J Med Genet, 1988, 29(2): 289-291.
[39]	Cao F, Xie X, Gollan T, et al. Comparison of gene-transfer efficiency in human embryonic stem cells [J]. Mol Imaging Biol, 2010, 12(1): 15-24.
[40]	Botto LD, Olney RS, Mastroiacovo P, et al. Chorionic villus sampling and transverse digital deficiencies: evidence for anatomic and gestational-age specificity of the digital deficiencies in two studies [J]. Am J Med Genet, 1996, 62(2): 173-178.
[41]	Firth H. Chorion villas sampling and limb deficiency-cause or coincidence? [J]. Prenat Diagn, 1997, 17(13): 1313-1330.
[42]	Cross HE, Maumenee AE. Ocular trauma during amniocentesis [J]. Arch Ophthalmol, 1973, 90(4): 303-304.
[43]	Epley SL, Hanson JW, Cruikshank DP. Fetal injury with midtrimester diagnostic amniocentesis [J]. Obstet Gynecol, 1979, 53(1): 77-80.
[44]	Cambiaghi S, Restano L, Cavalli R, et al. Skin dimpling as a consequence of amniocentesis [J]. J Am Acad Dermatol, 1998, 39(5 Pt 2): 888-890.
[45]	Sepúlveda W, Quiroz V, Fernández R. Trauma of the fetal vessels during amniocentesis [J]. Rev Chil Obstet Ginecol, 1984, 49(2): 99-103.
[46]	Squier M, Chamberlain P, Zaiwalla Z, et al. Five cases of brain injury following amniocentesis in mid-term pregnancy [J]. Dev Med Child Neurol, 2000, 42(8): 554-560.
[47]	Okyay RE, Gode F, Saatli B, et al. Late-onset maternal mortality after amniocentesis [J]. Eur J Obstet Gynecol Reprod Biol, 2011, 158(2): 367-368.

Please choose a citation manager

Content to export